TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
CLYM

Climb Bio Inc

Healthcare · Biotechnology

11.90$ -5.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CLYM
Line item 2019 2020 2021 2022 2023 2024 2025
– +15.1% +603.3% -22.1% -18.2% +96.6% -22.8%
– +3.4% +573.9% -9.3% -18.0% +40.5% -31.7%
– -3.5% +129.0% -7.1% +113.6% -6.3% -59.1%
– -3.5% +566.2% -9.5% -13.6% +41.3% -33.0%
– – – -0.5% -62.0% -54.6% –
– +291.2% +97.1% +4.0% -54.3% +84.9% +37.0%
– +291.2% +96.9% +1.1% -53.5% +74.1% +41.6%
– – – – +11.3% -53.0% +63.1%
– +67.9% +29.3% -46.6% -91.2% +968.2% +221.8%
– +4.6% +675.2% -23.0% -16.4% +96.9% -24.3%
– – – – – – –
– +0.0% +5.1% +114.6% +2.6% +78.5% +40.8%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?